What is Proton Pump Inhibitor Drug Market Scope?
Proton pump inhibitors (PPIs) are drugs that reduce the amount of acid in the stomach that is made by glands in the lining of the stomach. Proton pump inhibitors (PPIs) belong to a class of drugs whose main effect is a profound and sustained decrease in stomach acid production. There is no clear evidence within the drug class that one drug works better than another. They are the most potent acid secretion inhibitors available. This group of drugs followed and largely replaced another group of drugs with similar effects but a different mode of action, the H2-receptor antagonists. PPIs are among one of the top-selling drugs present in the world. The proton pump inhibitor drug class is on the World Health Organization's list of major drugs. Proton pump inhibitors are used to relieve the symptoms of acid reflux or gastroesophageal reflux disease (GERD). This is a condition in which food or liquid rises from the stomach to the esophagus (the tube from the mouth to the stomach). Treat a duodenal or stomach ulcer and treat damage to the lower esophagus caused by acid reflux.
The Proton Pump Inhibitor Drug market study is being classified by Type (Omeprazole, Lansoprazole, Pantoprazole, Rabeprazole and Others), by Application (Hospital, Clinics and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Proton Pump Inhibitor Drug market throughout the predicted period.
AstraZeneca (United Kingdom), Cadila Pharmaceuticals (India), Eisai (Japan), Eli Lilly and Company (United States), Janssen Pharmaceutica (Belgium), Pfizer Inc. (United States), Santarus, Inc. (United States), Wyeth (United States), Bayer AG (Germany), GlaxoSmithKline PLC (United Kingdom), Johnson & Johnson (United States) and Takeda Pharmaceuticals (Japan) are some of the key players profiled in the study.
Analyst at AMA have segmented the market study of Global Proton Pump Inhibitor Drug market by Type, Application and Region.
On the basis of geography, the market of Proton Pump Inhibitor Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Market Trend
- The Trend of Self Treatment Is Rapidly Growing Due To the Availability and Affordability of OTC Antacids
- A Shift in Government Focus on Promoting Consumer Accessibility
- The Increasing Shift in Lifestyle & Dietary Risk Factors Such As Obesity & High Fat Diet, Respectively
- The Increasing Occurrence of Gastroesophageal Reflux Disease
- The Rising Recognition of Novel Drug Delivery Systems
- The Increasing Shift from Prescription to OTC Drugs
- Increasing Consumer Acceptance of Novel Drug Delivery Systems and Launching Of New Products
- The Increasing Expenditure on Promotion in Developing Regions
- Side Effects Related To Proton Pump Inhibitor Drugs
- Increasing Use of Generic Products
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Proton Pump Inhibitor Drug, Suppliers and Distributors of Proton Pump Inhibitor Drug, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.